Cargando…
FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
Breast cancer is the most common cancer in women worldwide and the solid tumor type for which the highest number of drugs have been approved to date. This study examines new drug approvals for breast cancer by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EM...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072445/ https://www.ncbi.nlm.nih.gov/pubmed/32069837 http://dx.doi.org/10.3390/cancers12020437 |